These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 2956180

  • 1. T-cell immunity to murine Moloney sarcoma virus-induced tumours: L3T4+ T cells are necessary for resistance to primary sarcoma growth, but Lyt-2+ T cells are required for resistance to secondary tumour cell challenge.
    Bateman WJ, Jenkinson EJ, Owen JJ.
    Immunology; 1987 Jul; 61(3):317-20. PubMed ID: 2956180
    [Abstract] [Full Text] [Related]

  • 2. Cellular interactions and the role of interleukin 2 in the expression and induction of immunity against a syngeneic murine sarcoma.
    Chou T, Shu S.
    J Immunol; 1987 Sep 15; 139(6):2103-9. PubMed ID: 2957448
    [Abstract] [Full Text] [Related]

  • 3. Do L3T4+ T cells act as effector cells in protection against influenza virus infection.
    Lightman S, Cobbold S, Waldmann H, Askonas BA.
    Immunology; 1987 Sep 15; 62(1):139-44. PubMed ID: 2820868
    [Abstract] [Full Text] [Related]

  • 4. Functional activity in vivo of effector T cell populations. III. Protection against Moloney murine sarcoma virus (M-MSV)-induced tumors in T cell deficient mice by the adoptive transfer of a M-MSV-specific cytolytic T lymphocyte clone.
    Cerundolo V, Lahaye T, Horvath C, Zanovello P, Collavo D, Engers HD.
    Eur J Immunol; 1987 Feb 15; 17(2):173-8. PubMed ID: 3030766
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Requirements for the generation of a Lyt-2+ T-cell proliferative response to a syngeneic tumor in the absence of L3T4+ T-cells.
    Kern DE, Klarnet JP, Cheever MA, Greenberg PD.
    Cancer Res; 1990 Oct 01; 50(19):6256-63. PubMed ID: 2144789
    [Abstract] [Full Text] [Related]

  • 7. Importance of Lyt-2+ T-cells in the resistance of melphalan-cured MOPC-315 tumor bearers to a challenge with MOPC-315 tumor cells.
    Barker E, Mokyr MB.
    Cancer Res; 1988 Sep 01; 48(17):4834-42. PubMed ID: 3261626
    [Abstract] [Full Text] [Related]

  • 8. Phenotype analyses and cellular mechanisms of the pre-effector T-lymphocyte response to a progressive syngeneic murine sarcoma.
    Sakai K, Chang AE, Shu SY.
    Cancer Res; 1990 Jul 15; 50(14):4371-6. PubMed ID: 2114215
    [Abstract] [Full Text] [Related]

  • 9. Monoclonal antibody against IFN-gamma inhibits Moloney murine sarcoma virus-specific cytotoxic T lymphocyte differentiation.
    Zanovello P, Vallerani E, Biasi G, Landolfo S, Collavo D.
    J Immunol; 1988 Feb 15; 140(4):1341-4. PubMed ID: 2830339
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Autoimmune thyroiditis induced in mice depleted of particular T cell subsets. I. Requirement of Lyt-1 dull L3T4 bright normal T cells for the induction of thyroiditis.
    Sugihara S, Izumi Y, Yoshioka T, Yagi H, Tsujimura T, Tarutani O, Kohno Y, Murakami S, Hamaoka T, Fujiwara H.
    J Immunol; 1988 Jul 01; 141(1):105-13. PubMed ID: 2967864
    [Abstract] [Full Text] [Related]

  • 12. Dual regulation of resistance against Toxoplasma gondii infection by Lyt-2+ and Lyt-1+, L3T4+ T cells in mice.
    Suzuki Y, Remington JS.
    J Immunol; 1988 Jun 01; 140(11):3943-6. PubMed ID: 3259601
    [Abstract] [Full Text] [Related]

  • 13. Salmonella abortusovis infection in susceptible BALB/cby mice: importance of Lyt-2+ and L3T4+ T cells in acquired immunity and granuloma formation.
    Guilloteau L, Buzoni-Gatel D, Bernard F, Lantier I, Lantier F.
    Microb Pathog; 1993 Jan 01; 14(1):45-55. PubMed ID: 8321117
    [Abstract] [Full Text] [Related]

  • 14. The role of L3T4+ and Lyt-2+ T cells in the IgE response and immunity to Nippostrongylus brasiliensis.
    Katona IM, Urban JF, Finkelman FD.
    J Immunol; 1988 May 01; 140(9):3206-11. PubMed ID: 2966208
    [Abstract] [Full Text] [Related]

  • 15. Regulation of Ia+ reticulum cell sarcoma (RCS) growth in syngeneic SJL/J mice. I. Inhibition of tumor growth by passive administration of L3T4 monoclonal antibody before or after tumor inoculation.
    Ohnishi K, Bonavida B.
    J Immunol; 1987 Jun 15; 138(12):4524-9. PubMed ID: 2953807
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. T cell responses induced by the parenteral injection of antigen-modified syngeneic cells. I. Induction, characterization, and regulation of antigen-specific T helper cells involved in delayed-type hypersensitivity responses.
    Miller SD, Butler LD.
    J Immunol; 1983 Jul 15; 131(1):77-85. PubMed ID: 6190929
    [Abstract] [Full Text] [Related]

  • 18. Cell-mediated immunity to Moloney sarcoma virus in mice. II. Analysis of antigenic specificities involved in T lymphocyte-mediated in vivo rejection of murine sarcoma virus-induced tumors.
    Gorczynski RM, Knight RA.
    Eur J Immunol; 1975 Feb 15; 5(2):148-55. PubMed ID: 1086221
    [Abstract] [Full Text] [Related]

  • 19. In vitro differentiation of T-cells capable of mediating the regression of established syngeneic tumors in mice.
    Shu S, Chou T, Rosenberg SA.
    Cancer Res; 1987 Mar 01; 47(5):1354-60. PubMed ID: 3102046
    [Abstract] [Full Text] [Related]

  • 20. Primary and secondary in vitro generation of cytolytic T lymphocytes in the murine sarcoma virus system.
    Plata F, Cerottini JC, Brunner KT.
    Eur J Immunol; 1975 Apr 01; 5(4):227-33. PubMed ID: 185057
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.